|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
32
|
|
pubmed:dateCreated |
2008-11-7
|
|
pubmed:abstractText |
To assess the efficacy and toxicity of the addition of estramustine to docetaxel (D) for the treatment of metastatic hormone-refractory prostate cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BonnyMarie-AlixMA,
pubmed-author:ClausseMaryleneM,
pubmed-author:D'HondtLionelL,
pubmed-author:DopchieCatherineC,
pubmed-author:FilleulBertrandB,
pubmed-author:HonhonBrigitteB,
pubmed-author:JoustenPeterP,
pubmed-author:KergerJosephJ,
pubmed-author:MILLARP GPG,
pubmed-author:MachielsJean-PascalJP,
pubmed-author:MarcelisLucL,
pubmed-author:MazzeoFilomenaF,
pubmed-author:MoxhonAnne-MarieAM,
pubmed-author:TombalBertrandB,
pubmed-author:VerhoevenDidierD,
pubmed-author:VerschaeveVincentV
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5261-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18794543-Adenocarcinoma,
pubmed-meshheading:18794543-Aged,
pubmed-meshheading:18794543-Aged, 80 and over,
pubmed-meshheading:18794543-Antineoplastic Agents, Hormonal,
pubmed-meshheading:18794543-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18794543-Belgium,
pubmed-meshheading:18794543-Disease Progression,
pubmed-meshheading:18794543-Dose-Response Relationship, Drug,
pubmed-meshheading:18794543-Drug Resistance, Neoplasm,
pubmed-meshheading:18794543-Estramustine,
pubmed-meshheading:18794543-Humans,
pubmed-meshheading:18794543-Kaplan-Meier Estimate,
pubmed-meshheading:18794543-Male,
pubmed-meshheading:18794543-Middle Aged,
pubmed-meshheading:18794543-Neoplasm Metastasis,
pubmed-meshheading:18794543-Prednisone,
pubmed-meshheading:18794543-Prospective Studies,
pubmed-meshheading:18794543-Prostate-Specific Antigen,
pubmed-meshheading:18794543-Prostatic Neoplasms,
pubmed-meshheading:18794543-Taxoids,
pubmed-meshheading:18794543-Time Factors,
pubmed-meshheading:18794543-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.
|
|
pubmed:affiliation |
Department of Medical Oncology and Urology, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Brussels, Belgium. Jean-pascal.Machiels@uclouvain.be
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
